Zixin Pi

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1.

A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1.

Journal: International immunopharmacology

Published: May 12, 2026

Cystathionine γ-Lyase-Dependent S-Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis.

Cystathionine γ-Lyase-Dependent S-Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 20, 2025

Identification of a large homozygous RNF216 deletion in a Chinese patient with gordon holmes syndrome.

Identification of a large homozygous RNF216 deletion in a Chinese patient with gordon holmes syndrome.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 03, 2024

m6A RNA methylation: The latent string-puller in fibrosis.

m6A RNA methylation: The latent string-puller in fibrosis.

Journal: Life sciences

Published: February 12, 2024

The Role of Non-Coding RNA in Systemic Sclerosis: From Mechanism to Translation.

The Role of Non-Coding RNA in Systemic Sclerosis: From Mechanism to Translation.

Journal: Wiley interdisciplinary reviews. RNA

Published: February 08, 2024

ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.

ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.

Journal: International immunopharmacology

Published: March 05, 2023

Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.

Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.

Journal: International immunopharmacology

Published: November 04, 2022

Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases.

Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases.

Journal: Current medicinal chemistry

Published: September 06, 2022

Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.

Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.

Journal: Pharmacological research

Published: October 03, 2021

Occludin Promotes Adhesion of CD8+ T Cells and Melanocytes in Vitiligo via the HIF-1α Signaling Pathway.

Occludin Promotes Adhesion of CD8+ T Cells and Melanocytes in Vitiligo via the HIF-1α Signaling Pathway.

Journal: Oxidative medicine and cellular longevity

Published: September 13, 2021

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak.

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak.

Journal: Clinics in dermatology

Published: December 20, 2020

Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.

Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.

Journal: BioMed research international

Published: October 27, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026